Ortho Clinical Diagnostics Holdings (Ortho Clinical Diagnostics Holdings) Debt-to-Asset : 0.68 (As of Mar. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Ortho Clinical Diagnostics Holdings Debt-to-Asset?

Ortho Clinical Diagnostics Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2022 was $76 Mil. Ortho Clinical Diagnostics Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2022 was $2,177 Mil. Ortho Clinical Diagnostics Holdings's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2022 was $3,316 Mil. Ortho Clinical Diagnostics Holdings's debt to asset for the quarter that ended in Mar. 2022 was 0.68.

Ortho Clinical Diagnostics Holdings Debt-to-Asset Historical Data

The historical data trend for Ortho Clinical Diagnostics Holdings's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ortho Clinical Diagnostics Holdings Debt-to-Asset Chart

Ortho Clinical Diagnostics Holdings Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Debt-to-Asset

0.99

1.01

1.10

0.67

Ortho Clinical Diagnostics Holdings Quarterly Data
	Dec17	Dec18	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22
Debt-to-Asset	Get a 7-Day Free Trial							0.71	0.70	0.69	0.67	0.68

Competitive Comparison of Ortho Clinical Diagnostics Holdings's Debt-to-Asset

For the Diagnostics & Research subindustry, Ortho Clinical Diagnostics Holdings's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ortho Clinical Diagnostics Holdings's Debt-to-Asset Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Ortho Clinical Diagnostics Holdings's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Ortho Clinical Diagnostics Holdings's Debt-to-Asset falls into.

Ortho Clinical Diagnostics Holdings Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Ortho Clinical Diagnostics Holdings's Debt-to-Asset for the fiscal year that ended in Dec. 2021 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(76.8	+	2186.7)	/	3363.8
	=	0.67

Ortho Clinical Diagnostics Holdings's Debt-to-Asset for the quarter that ended in Mar. 2022 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(75.7	+	2177.1)	/	3316.4
	=	0.68

Ortho Clinical Diagnostics Holdings (NAS:OCDX) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Ortho Clinical Diagnostics Holdings Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Ortho Clinical Diagnostics Holdings's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Ortho Clinical Diagnostics Holdings (Ortho Clinical Diagnostics Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Ortho Clinical Diagnostics Holdings PLC (NAS:OCDX) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

1001 Route 202, Raritan, NJ, USA, 08869

Website

https://www.orthoclinicaldiagnostics.com

Ortho Clinical Diagnostics Holdings PLC offers in vitro diagnostics solutions and services. It provides diagnostic testing solutions to the clinical laboratory and transfusion medicine communities. The company operates through three geographic segments such as Americas, EMEA, Greater China, and Other. Americas segment generates most of the revenue for the firm.

Executives

Robert Clifton Yates	director	C/O ORTHO CLINICAL DIAGNOSTICS HOLDINGS 1001 ROUTE 202 RARITAN NJ 08869
Chockalingam Palaniappan	officer: Chief Innovation Officer	C/O ORTHO CLINICAL DIAGNOSTICS HOLDINGS 1001 ROUTE 202 RARITAN NJ 08869
Christopher M Smith	director, officer: Chairman and CEO	125 CONSTITUTION DRIVE, MENLO PARK CA 94025
Michael S. Iskra	officer: Executive Vice President	C/O ORTHO CLINICAL DIAGNOSTICS HOLDINGS, 1001 ROUTE 202, RARITAN NJ 08869
Joseph M Busky	officer: Chief Financial Officer	1717 DEERFIELD ROAD, DEERFIELD IL 60015
Michael A. Schlesinger	officer: EVP, GC and Secretary	C/O ORTHO CLINICAL DIAGNOSTICS HOLDINGS 1001 ROUTE 202 RARITAN NJ 08869
Carlyle Partners Vi Cayman Holdings, L.p.	10 percent owner	C/O WALKERS CORPORATE LIMITED, CAYMAN CORPORATE CENTRE, 27 HOSPITAL RD., GEORGE TOWN, GRAND CAYMAN E9 KY1-9008
Tc Group Vi Cayman, L.l.c.	10 percent owner	C/O THE CARLYLE GROUP, SUITE 220 SOUTH, 1001 PENNSYLVANIA AVENUE, N.W., WASHINGTON DC 20004
Tc Group Vi Cayman, L.p.	10 percent owner	C/O WALKERS CORPORATE LIMITED, CAYMAN CORPORATE CENTRE, 27 HOSPITAL RD., GEORGE TOWN, GRAND CAYMAN E9 KY1-9008
Cg Subsidiary Holdings L.l.c.	10 percent owner	C/O THE CARLYLE GROUP, SUITE 220 SOUTH, 1001 PENNSYLVANIA AVENUE, N.W., WASHINGTON DC 20004
Tc Group Cayman Investment Holdings Sub L.p.	10 percent owner	C/O WALKER CORPORATE SERVICES LIMITED, 190 ELGIN AVENUE, GEORGE TOWN, GRAND CAYMAN E9 KY1-9001
Carlyle Holdings Ii L.l.c.	10 percent owner	C/O THE CARLYLE GROUP L.P., 1001 PENNSYLVANIA AVENUE, NW, WASHINGTON DC 20004-2505
Carlyle Holdings Ii Gp L.l.c.	10 percent owner	C/O THE CARLYLE GROUP L.P., 1001 PENNSYLVANIA AVENUE, NW, WASHINGTON DC 20004-2505
Carlyle Group Inc.	10 percent owner	C/O THE CARLYLE GROUP, 1001 PENNSYLVANIA AVENUE, N.W., WASHINGTON DC 20004
Tc Group Cayman Investment Holdings, L.p.	10 percent owner	C/O WALKERS CORPORATE SERVICES LIMITED, 190 ELGIN AVENUE, GEORGE TOWN, GRAND CAYMAN E9 KY1-9001